Advertisement BioScrip names new COO - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

BioScrip names new COO

BioScrip, a specialty pharmaceutical healthcare organization, has appointed Richard Smith appointed as its new president and COO.

Mr Smith will report to Richard Friedman, BioScrip’s chairman and CEO, and will begin work on or before January 2, 2009, after a short transition period with his current employer.

Most recently, Mr Smith was CEO and director of Byram Healthcare Centers, a provider of medical supplies and pharmacy items to long-term chronic patients. Previously, Mr Smith was president and COO of Option Care, a specialty pharmaceutical company.

Mr Friedman said: “Rick Smith is clearly a results-driven and entrepreneurial executive; we are pleased to have him join our senior management team. His demonstrated track record of building specialty pharmacy programs, establishing clinical centers of excellence, driving market leadership, growing revenue and earnings, and increasing shareholder value will prove vital as BioScrip progresses to the next phase of its development.”